Literature DB >> 27143673

Editorial Commentary: Fecal ESBL Screening: Are We Ready for This Information?

Sarah E Turbett1, Michael K Mansour2.   

Abstract

Keywords:  ESBL; Enterobacteriaceae; fecal colonization; infection control; screening

Mesh：

Substances：

Year:  2016        PMID： 27143673      PMCID： PMC4946017          DOI： 10.1093/cid/ciw288

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  20 in total

Review 1.  Management of multidrug-resistant organisms in health care settings, 2006.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

2.  Donor feces infusion for eradication of Extended Spectrum beta-Lactamase producing Escherichia coli in a patient with end stage renal disease.

Authors:  R Singh; E van Nood; M Nieuwdorp; B van Dam; I J M ten Berge; S E Geerlings; F J Bemelman
Journal:  Clin Microbiol Infect       Date:  2014-07-08       Impact factor: 8.067

3.  Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies.

Authors:  M Arnan; C Gudiol; L Calatayud; J Liñares; M Á Dominguez; M Batlle; J M Ribera; J Carratalà; F Gudiol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-10-30       Impact factor: 3.267

4.  Intervention to reduce transmission of resistant bacteria in intensive care.

Authors:  W Charles Huskins; Charmaine M Huckabee; Naomi P O'Grady; Patrick Murray; Heather Kopetskie; Louise Zimmer; Mary Ellen Walker; Ronda L Sinkowitz-Cochran; John A Jernigan; Matthew Samore; Dennis Wallace; Donald A Goldmann
Journal:  N Engl J Med       Date:  2011-04-14       Impact factor: 91.245

Review 5.  Diagnosis and treatment of Clostridium difficile in adults: a systematic review.

Authors:  Natasha Bagdasarian; Krishna Rao; Preeti N Malani
Journal:  JAMA       Date:  2015-01-27       Impact factor: 56.272

Review 6.  Risk of infection following colonization with carbapenem-resistant Enterobactericeae: A systematic review.

Authors:  Jessica Tischendorf; Rafael Almeida de Avila; Nasia Safdar
Journal:  Am J Infect Control       Date:  2016-02-15       Impact factor: 2.918

7.  Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme.

Authors:  D Pittet; S Hugonnet; S Harbarth; P Mourouga; V Sauvan; S Touveneau; T V Perneger
Journal:  Lancet       Date:  2000-10-14       Impact factor: 79.321

8.  Control of vancomycin-resistant enterococcus in health care facilities in a region.

Authors:  B E Ostrowsky; W E Trick; A H Sohn; S B Quirk; S Holt; L A Carson; B C Hill; M J Arduino; M J Kuehnert; W R Jarvis
Journal:  N Engl J Med       Date:  2001-05-10       Impact factor: 91.245

9.  Decolonization of intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial.

Authors:  Benedikt Huttner; Thomas Haustein; Ilker Uçkay; Gesuele Renzi; Andrew Stewardson; Danièle Schaerrer; Americo Agostinho; Antoine Andremont; Jacques Schrenzel; Didier Pittet; Stephan Harbarth
Journal:  J Antimicrob Chemother       Date:  2013-05-29       Impact factor: 5.790

10.  Is surveillance for multidrug-resistant enterobacteriaceae an effective infection control strategy in the absence of an outbreak?

Authors:  Michael A Gardam; Lori L Burrows; Julianne V Kus; James Brunton; Donald E Low; John M Conly; Atul Humar
Journal:  J Infect Dis       Date:  2002-11-14       Impact factor: 5.226
View more
  2 in total

1.  Subsequent infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in patients with prior infection or fecal colonization.

Authors:  Anna Lindblom; Nahid Karami; Tim Magnusson; Christina Åhrén
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-23       Impact factor: 3.267

2.  High prevalence of extended-spectrum beta-lactamase organisms and the COVID-19 pandemic impact on donor recruitment for fecal microbiota transplantation in Hong Kong.

Authors:  Yuk Kam Yau; Wing Yan Joyce Mak; Nok Shun Rashid Lui; Wai Yin Rita Ng; Choi Yan Kitty Cheung; Ying Lee Amy Li; Yuet Ling Jessica Ching; Miu Ling Chin; Ho Shing Louis Lau; Ka Leung Francis Chan; Kay Sheung Paul Chan; Siew Chien Ng
Journal:  United European Gastroenterol J       Date:  2021-10-08       Impact factor: 4.623
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.